Paul D. Rubin, Chief Medical Officer at BioAge Labs, Inc. (BIOA), sold 7,433 shares at $18.75 ($139K) on 2026-02-02, disclosed to the SEC on 2026-02-03.
Scheduled sale ($139k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |
| BIOA | SELL | 2025-12-05 | $1.4M | — | Filing → |